scispace - formally typeset
Journal ArticleDOI

4. Modelling Survival Data in Medical Research

About
This article is published in Journal of The Royal Statistical Society Series A-statistics in Society.The article was published on 1995-01-01. It has received 1092 citations till now. The article focuses on the topics: Medical research.

read more

Citations
More filters
Journal ArticleDOI

Human Papillomavirus Infection in Women Infected with the Human Immunodeficiency Virus

TL;DR: HIV-seropositive women have a high rate of persistent HPV infections with the types of HPV that are strongly associated with the development of high-grade squamous intraepithelial lesions and invasive cervical cancer.
Journal ArticleDOI

Policing the Bargain: Coalition Government and Parliamentary Scrutiny

TL;DR: In this paper, the authors argue that parties will make use of parliamentary scrutiny of "hostile" ministerial proposals to overcome the potential problems of delegation and enforce the coalition bargain, and their analysis of original data on government bills in Germany and the Netherlands supports this argument.
Journal ArticleDOI

Prognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis

TL;DR: The indexing of LVM by height(2.7) provides more powerful prediction of mortality and cardiovascular outcomes than the BSA-based method, and the use of this index appears to be appropriate in patients undergoing dialysis.
Journal ArticleDOI

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension

TL;DR: Raised N-TproBNP levels are directly related to the severity of PAH and are associated with a greater than three-fold increase in mortality, and may indicate therapeutic failure.
References
More filters
Journal ArticleDOI

Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

TL;DR: Hyperphosphatemia and hyperparathyroidism were significantly associated with all-cause, cardiovascular, and fracture-related hospitalization, and the population attributable risk percentage for disorders of mineral metabolism was 17.5%, owing largely to the high prevalence of hyperph phosphatemia.
Journal ArticleDOI

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

TL;DR: Sunitinib demonstrates longer overall survival compared with IFN-alpha plus improvement in response and progression-free survival in the first-line treatment of patients with metastatic RCC, highlighting an improved prognosis in patients with RCC in the era of targeted therapy.
Journal ArticleDOI

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

TL;DR: Five prognostic factors for predicting survival were identified and used to categorize patients with metastatic RCC into three risk groups, for which the median survival times were separated by 6 months or more.